Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Stenocare AS's share price for the quarter that ended in Mar. 2026 was kr1.04. Stenocare AS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 43.20 Mil. Therefore, Stenocare AS's market cap for the quarter that ended in Mar. 2026 was kr44.92 Mil.
Stenocare AS's quarterly market cap
increased
from Sep. 2025 (kr45.64 Mil) to Dec. 2025 (kr63.93 Mil) but then
declined
from Dec. 2025 (kr63.93 Mil) to Mar. 2026 (kr44.92 Mil).
Stenocare AS's annual market cap
declined
from Dec. 2023 (kr46.08 Mil) to Dec. 2024 (kr25.97 Mil) but then
increased
from Dec. 2024 (kr25.97 Mil) to Dec. 2025 (kr63.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Stenocare AS's Enterprise Value for Today is kr44.06 Mil.
Stenocare AS (OCSE:STENO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Stenocare AS Market Cap Related Terms
Stenocare AS Market Cap Historical Data
* Premium members only.
The historical data trend for Stenocare AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:STENO vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stenocare AS Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's Market Cap distribution charts can be found below:
* The bar in red indicates where Stenocare AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Stenocare AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stenocare AS (OCSE:STENO) has a Market Cap of kr43.20 Mil as of Jul. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stenocare AS and its competitors. According to the industry distribution chart, Stenocare AS ranks #904 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 88.3%.
Is Stenocare AS's Market Cap too high?
Stenocare AS's current Market Cap is kr43.20 Mil. Based on the distribution chart, Stenocare AS ranks #904 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Stenocare AS has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Stenocare AS's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Stenocare AS ranks #904 out of 1024 companies for Market Cap. This places Stenocare AS in the lower half of its industry. The industry median Market Cap is 214.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.09, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Stenocare AS and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stenocare AS's current Market Cap is kr43.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stenocare AS stock overvalued right now?
Based on GuruFocus' analysis, Stenocare AS (OCSE:STENO) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.31, compared to a current price of kr1.00 — trading 56.7% below its estimated fair value. The current Market Cap is kr43.20 Mil. Stenocare AS's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Stenocare AS (OCSE:STENO), the current Market Cap is kr43.20 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stenocare AS (OCSE:STENO) Overvalued in 2026?
Based on GuruFocus' analysis, Stenocare AS stock appears to be undervalued.
The current stock price of kr1.00 is trading 56.7% below its estimated GF Value™ of kr2.31.
GuruFocus considers Stenocare AS to be Possible Value Trap.
Key valuation signals for OCSE:STENO:
Market Cap: kr43.20 Mil
GF Value™: kr2.31 vs. price of kr1.00 (56.7% below fair value)
No single metric tells the full story. See the OCSE:STENO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway.
50GF Score
Get the complete analysis for OCSE:STENO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:STENO has been successfully added to your 
